评估手术特异性阿片类药物处方建议对盆腔器官脱垂手术后阿片类药物管理的影响
本研究前瞻性评估盆腔器官脱垂手术患者阿片类药物处方模式,并比较实施手术特异性处方建议前后两个队列。实施建议后,处方口服吗啡当量中位数从200 mg降至112.5 mg(P<.0001),剩余阿片类药物显著减少(P<.0001),药物补充率增加(18% vs 3.5%,P=.03),但满意度相似(P=.87)。结论认为手术特异性处方建议可将出院时阿片类药物处方量减少约一半,且不损害患者满意度。
要点
- 实施手术特异性阿片类药物处方建议后,处方口服吗啡当量中位数从200 mg降至112.5 mg(P<.0001)。
- 干预后每位患者剩余阿片类药物量显著减少(P<.0001),止痛药补充率从3.5%升至18%(P=.03)。
- 两个队列患者疼痛管理满意度相似(P=.87),减少阿片类药物处方未对满意度产生不良影响。
核心结论
- 采用手术特异性阿片类药物处方建议可将出院时阿片类药物处方量减少约一半,且未对患者满意度产生不良影响。
研究设计与样本
- 前瞻性评估8个月期间接受盆腔器官脱垂手术(阴道、开腹或机器人)女性的阿片类药物处方模式、患者使用、药物补充及满意度。
- 两个队列按手术是否在实施手术特异性阿片类药物处方建议之前或之后进行分层,基线队列57例,实施建议后队列39例,共96例。
- 术后2周通过电话评估阿片类药物使用(药片计数)、药物补充及疼痛管理满意度,处方和使用量转换为口服吗啡当量记录。
主要发现
- 基线队列中,处方的口服吗啡当量消耗了32.8%(3607/11007 mg)。
- 实施处方建议后,处方口服吗啡当量中位数从200 mg(四分位距150,225)降至112.5 mg(四分位距22.5,112.5;P<.0001)。
- 与实施建议前可能处方的量相比,总处方口服吗啡当量减少了45%。
- 每位患者剩余阿片类药物量显著减少(P<.0001)。
- 干预后止痛药补充率增加(18% vs 3.5%;P=.03),而两个队列满意度评分相似(P=.87)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nationally, there is increasing concern regarding the volume of opioid medications prescribed postoperatively and the rate of prescription opioid-related adverse events. In evaluation of this, several reports have identified significant variability in postoperative opioid-prescribing patterns, including quantities exceeding patient's needs, especially after minor surgical procedures. However, data regarding patient's postoperative opioids needs following surgery for pelvic organ prolapse are sparse. OBJECTIVE: To design procedure-specific opioid-prescribing recommendations for pelvic organ prolapse surgeries and evaluate their impact on opioid stewardship. STUDY DESIGN: We prospectively evaluated opioid-prescribing patterns, patient use, medication refills, and patient satisfaction in women undergoing prolapse surgery (ie, vaginal, abdominal, or robotic) during an 8-month time period. Two cohorts of women, stratified by whether they had surgery before or after implementation of procedure-specific opioid-prescribing recommendations, were evaluated. Postoperative opioid usage (assessed via pill count), medication refills, and satisfaction with pain management after hospital dismissal were evaluated by telephone call 2 weeks after surgery. Postoperative opioid prescribing and use were recorded after conversion to oral morphine equivalents. RESULTS: Overall, 96 women were included, 57 in the initial baseline cohort, and 39 following implementation of the prescribing recommendations. In the initial cohort, 32.8% of the prescribed oral morphine equivalents (3607/11,007 mg) were consumed. Following implementation of the prescribing recommendations, median oral morphine equivalents prescribed decreased from 200 mg oral morphine equivalents (interquartile range 150, 225) to 112.5 mg oral morphine equivalents (interquartile range 22.5, 112.5; P<.0001). The total oral morphine equivalents prescribed decreased by 45% when compared with the volume that would have been prescribed before implementing the recommendations. The amount of leftover opioids per patient significantly decreased as well (P<.0001). Pain medication refills increased after the intervention (18% vs 3.5%; P=.03), whereas satisfaction scores were similar in both cohorts (P=.87). CONCLUSIONS: By using procedure-specific opioid prescribing recommendations, we decreased the number of opioids prescribed at hospital dismissal by roughly one half. Decreased opioid prescribing did not adversely impact patient satisfaction.
引用
- Linder BJ, Occhino JA, Wiest SR, et al. Assessing the impact of procedure-specific opioid prescribing recommendations on opioid stewardship following pelvic organ prolapse surgery. Am J Obstet Gynecol. 2019. PMID: 31226293. doi:10.1016/j.ajog.2019.06.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。